Overview

Download the Presentation as a PDF

Objectives

As a result of attending this session, participants will be able to:

• —Recognize new developments in the field of cardiology
• —Review the evidence for colchicine and omega-3s in CVD protection
• —Identify situations in which NOAC use is appropriate in valvular a.fib
• —Recognize the role of the placebo effect in patients complaining of statinside effects
• —Recognize the equivalence of ticagrelor and clopidogrel in some clinical situations

Presentations by Christopher Labos

• Mon-30 from 08:30 - 10:35 in room Remote presentation
  Plenary - 1
  Atrial fibrillation: What's new and what do you need to know
• Mon-30 from 11:00 - 12:00 in room Remote presentation
  Important new cardio literature for the family doctor - Christopher Labos
  Important new cardio literature for the family doctor